Biocryst Pharmaceuticals INC (BCRX) — SC 13G/A Filings
All SC 13G/A filings from Biocryst Pharmaceuticals INC. Browse 8 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (8)
- SC 13G/A Filing — Nov 7, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Oct 17, 2024
- SC 13G/A Filing — Sep 10, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Vanguard Discloses 12.96% Stake in BioCryst Pharma
— Feb 13, 2024 Risk: low
The Vanguard Group, a major investment firm, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in BioCryst Pharmaceuticals Inc. As of Dec -
BlackRock Amends BioCryst Stake: Passive Investment Update
— Jan 24, 2024
BlackRock Inc. filed an amended SC 13G/A on January 24, 2024, indicating a change in its ownership stake in BioCryst Pharmaceuticals Inc. as of December 31, 202 -
State Street Corp. Amends BioCryst Pharma Stake Filing
— Jan 24, 2024
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 24, 2024, indicating its ownership of BioCryst Pharmaceuticals Inc
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX